$CBAY CymaBay Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in CymaBay Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in CymaBay Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in CymaBay Therapeutics, Inc. for free.

CIK Number: 0001042074
IRS Number: 943103561
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CBAY
Company Address: 7575 GATEWAY BOULEVARD SUITE 110 NEWARK 94560
Phone number: 510-293-8800
Former name: METABOLEX INC, date of change: 1997-07-10

CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of biopharmaceutical products. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Market Capitalization: $52.52M
Prev close: $2.05
Average Daily Volume: 363,679
Days Low: $2.01
Year Low: $0.82
Year High: $3.04

CymaBay Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Booth Robert F.Director00Jan 31 201920 days ago
Boudes Pol FChief Medical Officer00Jan 31 201920 days ago
Dickinson KlaraChief Regulatory Officer00Jan 31 201920 days ago
EMSTER KURT VONDirector184,528378,282shares bought: 153,846 / shares sold: -1,534,307 STRONG SELLJan 31 201920 days ago
GOLDFISCHER CARLDirector2,3354,787shares bought: 44,675 / shares sold: -44,675 HOLDFeb 08 201912 days ago
Loewy Caroline MDirector00Jan 31 201920 days ago
McWherter CharlesChief Science Officer10,30021,115shares bought: 13,000 / shares sold: 0 STRONG BUYJan 31 201920 days ago
Menold DanielVice President, Finance5,00010,250shares bought: 5,000 / shares sold: -5,000 HOLDJan 31 201920 days ago
Quinlan Paul TGeneral Counsel00Jan 31 201920 days ago
Shah SujalChief Executive Officer110,000225,500shares bought: 90,000 / shares sold: 0 STRONG BUYJan 31 201920 days ago
STEIN EVAN A.Director00Jan 31 201920 days ago
TRUEX PAUL FDirector00Jan 31 201920 days ago
Weiland Robert J.Director00Jan 31 201920 days ago
Wills Robert JamesDirector25,20051,660shares bought: 30,000 / shares sold: 0 STRONG BUYJan 31 201920 days ago

View all CymaBay Therapeutics, Inc. insiders.

CymaBay Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorOption ExerciseM5.509,34051,3700
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorOption ExerciseM5.002,33511,6750
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorSellS9.0211,675105,328011.7 K to 0 (-100.00 %)
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorBuyM5.509,34051,37011,6752.3 K to 11.7 K (+400.00 %)
Feb 08 2019CBAYCymaBay Therapeuti ...GOLDFISCHER CARLDirectorBuyM5.002,33511,6752,3350 to 2.3 K
Jan 31 2019CBAYCymaBay Therapeuti ...Menold DanielVice President, Fin ...Option ExerciseA8.4369,156582,98569,156
Jan 31 2019CBAYCymaBay Therapeuti ...Dickinson KlaraChief Regulatory Of ...Option ExerciseA8.43138,3121,165,970138,312
Jan 31 2019CBAYCymaBay Therapeuti ...Quinlan Paul TGeneral CounselOption ExerciseA8.4386,445728,73186,445
Jan 31 2019CBAYCymaBay Therapeuti ...Boudes Pol FChief Medical Offic ...Option ExerciseA8.43138,3121,165,970138,312
Jan 31 2019CBAYCymaBay Therapeuti ...McWherter CharlesChief Science Offic ...Option ExerciseA8.43172,8911,457,471172,891
Jan 31 2019CBAYCymaBay Therapeuti ...Shah SujalChief Executive Off ...Option ExerciseA8.43328,4922,769,188328,492
Jan 31 2019CBAYCymaBay Therapeuti ...Wills Robert JamesDirectorOption ExerciseA8.4327,705233,55327,705
Jan 31 2019CBAYCymaBay Therapeuti ...Weiland Robert J.DirectorOption ExerciseA8.4327,705233,55327,705
Jan 31 2019CBAYCymaBay Therapeuti ...TRUEX PAUL FDirectorOption ExerciseA8.4327,705233,55327,705
Jan 31 2019CBAYCymaBay Therapeuti ...STEIN EVAN A.DirectorOption ExerciseA8.4327,705233,55327,705

View all CymaBay Therapeutics, Inc. insider transactions.